The inflammatory CC chemokine scavenging receptor ACKR2 has been proposed as a regulator of cutaneous inflammation in psoriasis with a two-fold increased expression in psoriasis skin lesions and > tenfold upregulation in psoriasis uninvolved skin, with reduced expression following mild trauma [13]. Here, ACKR2 is linked to psoriasis.